Skip to content

A study to assess the safety and effectiveness of a skincare product

To evaluate the in-vivo safety and efficacy of a skin care formulation in terms of dark spots and pore control on healthy female subjects - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109076
Enrollment
36
Registered
2026-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Pigmentation Serum: Product is applied on the whole face twice a day for the period of 56 days Control Intervention1: Nil: NA

Sponsors

Aesthex Labs Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Indian Female subjects Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup) Between 24 and 44 years of age. Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar .) Having normal skin type with visible age spots Having under eye dark circles Having visible pores.

Exclusion criteria

Exclusion criteria: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months Having refused to give her assent by not signing the consent form Taking part in another study liable to interfere with this study Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months) Having a progressive asthma. Being epileptic. Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) Having cutaneous hypersensitivity Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products. Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) Having consumed caffeine-based products (coffee, cola, tea ), alcohol, highly spiced foods and/or smoked in the two hours preceding the measurements Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months. Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit Having applied a cosmetic product (including make-up) or skin care product on the studied areas the first day of the study (only face cleaned with water is accepted).

Design outcomes

Primary

MeasureTime frame
Reduction in dark spots and pore controlTimepoint: Baseline, Day 28, Day 56

Secondary

MeasureTime frame
NilTimepoint: NA

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

niharika@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026